daptomycin
NDC 14335-120, daptomycin, injection, powder, lyophilized, for suspension, from Hainan Poly Pharm., Co., Ltd..
- Product NDC
- 14335-120
- Status
- Listed
- Labeler
- Hainan Poly Pharm., Co., Ltd.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215890
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14335-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPTOMYCIN500 mg/20mL
Pharmacologic classes
Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14335-120-01 | 14335012001 | 20 mL in 1 VIAL, SINGLE-DOSE (14335-120-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6ec53f7e-9a5f-4b24-84e9-c94325750e32
Use it
Look up 14335-120 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14335-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14335-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.